Technical Analysis for YMAB - Y-mAbs Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 20.47 -4.44% -0.95
YMAB closed down 4.44 percent on Monday, December 17, 2018, on 61 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical YMAB trend table...

Date Alert Name Type % Chg
Dec 17 Lower Bollinger Band Walk Weakness 0.00%
Dec 17 Wide Bands Range Expansion 0.00%
Dec 17 Down 3 Days in a Row Weakness 0.00%
Dec 17 Lower Bollinger Band Touch Weakness 0.00%
Dec 17 Oversold Stochastic Weakness 0.00%
Dec 14 Lower Bollinger Band Walk Weakness -4.44%
Dec 14 Inside Day Range Contraction -4.44%
Dec 14 Lower Bollinger Band Touch Weakness -4.44%
Dec 14 Oversold Stochastic Weakness -4.44%
Dec 13 Doji - Bullish? Reversal -5.14%

Older signals for YMAB ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Y-mAbs Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody therapeutic products for cancer treatment in the United States. It is developing naxitamab for the treatment of pediatric patients with relapsed or refractory, high-risk neuroblastoma, as well as other GD2 positive tumors; and omburtamab for the treatment of pediatric patients with central nervous system/leptomeningeal metastases, desmoplastic small round cell tumors, diffuse intrinsic pontine glioma, and other B7-H3 positive tumors. The company has a license and research collaboration agreement with Memorial Sloan-Kettering Cancer Center. Y-mAbs Therapeutics, Inc. was founded in 2015 and is headquartered in New York, New York.
Is YMAB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 31.0
52 Week Low 18.0
Average Volume 106,276
200-Day Moving Average 0.0
50-Day Moving Average 23.5818
20-Day Moving Average 23.8505
10-Day Moving Average 22.494
Average True Range 2.1979
ADX 22.01
+DI 10.5367
-DI 20.2093
Chandelier Exit (Long, 3 ATRs ) 20.9913
Chandelier Exit (Short, 3 ATRs ) 26.5937
Upper Bollinger Band 27.4526
Lower Bollinger Band 20.2484
Percent B (%b) 0.03
BandWidth 30.205656
MACD Line -0.8882
MACD Signal Line -0.4501
MACD Histogram -0.4381
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.44
Resistance 3 (R3) 23.61 22.80 22.95
Resistance 2 (R2) 22.80 22.04 22.71 22.78
Resistance 1 (R1) 21.63 21.57 21.23 21.46 22.61
Pivot Point 20.82 20.82 20.61 20.73 20.82
Support 1 (S1) 19.65 20.06 19.25 19.48 18.33
Support 2 (S2) 18.84 19.59 18.75 18.16
Support 3 (S3) 17.67 18.84 18.00
Support 4 (S4) 17.50